Pulmonary delivery of mucosal nanovaccines-Reference-Cited by-同舟云学术

Pulmonary delivery of mucosal nanovaccines

Published:2022 Issue:2 Volume:14 Page:263-276
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Tang Wei¹,Zhang Yu²,Zhu Guizhi²^ORCID

Affiliation:

1. Department of Pharmacy and Department of Diagnostic Radiology, Faculty of Science and Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119077, Singapore

2. Department of Pharmaceutics and Center for Pharmaceutical Engineering and Sciences, Institute for Structural Biology and Drug Discovery, School of Pharmacy, The Developmental Therapeutics Program, Massey Cancer Center, Richmond, VA 23298, USA

Abstract

Mucosal vaccines can elicit both systemic and mucosal immunity to treat/prevent local mucosal or distant or systemic immune diseases and infection.

Funder

National University of Singapore

National Institute of General Medical Sciences

National Institute of Neurological Disorders and Stroke

National Center for Advancing Translational Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link